HCW Biologics Inc. (HCWB) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -1.58M | -3.36M | -3.24M | -3.28M | -3.51M | -2.83M | -2.93M | -4.86M | -3.6M | -3.89M | -5.59M | -9.39M | -3.64M | -3.79M | -2.31M | -2.69M | -1.59M | -3.38M | -5.12M | -990.44K |
| Operating CF Margin % | -24.07% | -12423.24% | -20760.87% | -50111.5% | -69375.24% | -718.05% | -686.28% | -785.68% | -319.86% | -294.17% | -655.17% | -1507.99% | -8686.61% | -282.47% | -127.96% | -592.47% | -51.07% | - | - | - |
| Operating CF Growth % | 55.17% | -18.37% | -10.71% | 32.49% | 2.5% | 27.21% | 47.64% | 48.23% | 0.94% | -2.78% | -141.46% | -249.16% | -128.51% | -12.22% | 54.78% | -171.58% | -6.87% | 4.54% | - | - |
| Net Income | 3.47M | 719.23K | -4.55M | -1.93M | -2.2M | -3.37M | -3.9M | -15.28M | -7.47M | -10.68M | -4.94M | -4.3M | -5.07M | -5.42M | -3.91M | -3.51M | -2.06M | -3.17M | -4.09M | -2.75M |
| Depreciation & Amortization | 142.05K | 156.94K | 173.91K | 291.92K | 419.01K | 682.51K | 128.45K | 129.93K | 243.5K | 274.55K | 277.45K | 284.33K | 298.85K | 261.16K | 164.33K | 149.58K | 142.78K | 95.58K | 122.46K | 154.87K |
| Stock-Based Compensation | 10.02K | 9.18K | 0 | 278.31K | 275.64K | 292.07K | 232.43K | 239.82K | 244.69K | 261.27K | 219.85K | 263.42K | 259.21K | 286.19K | 302.32K | 271.33K | 260.35K | 0 | 1.66K | 10.22K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -4.17M | -3.88M | 1.35M | -1.88M | 150K | 0 | 0 | 0 | -418 | 5.25M | -41.26K | -111.57K | -112.29K | -66.55K | 44.84K | 24.84K | 185.33K | 455.06K | 0 | 0 |
| Working Capital Changes | -1.03M | -361.65K | -213.43K | -44.97K | -2.16M | -436.19K | 614.93K | 10.05M | 3.38M | 1M | -1.11M | -5.52M | 986.71K | 1.15M | 1.09M | 374.97K | -123.42K | -753.84K | -1.15M | 1.59M |
| Change in Receivables | -42.67K | -1.51K | -9.06K | 65.88K | 494.71K | 69.64K | 3.13K | 248.91K | 631.87K | -825.68K | -2.87K | -454.48K | 164.97K | -62.14K | -8.62K | 206.07K | -420.01K | -63K | -20K | 1.25M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.34M | -339.23K | -362.12K | -373.9K | -2.4M | -508.4K | 486.56K | 9.4M | 2.5M | 1.23M | -820.12K | 494.25K | 718.67K | 621.19K | 1.14M | -276.64K | -1.07M | -72.91K | 489.76K | 757.91K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | -113.41K | -37.06K | 18.57K | -129.71K | -3.72M | 9.37M | -1.56M | -300.38K | -68.69K | 6.81M | -12.91K | 7.98M | -23.9K | -34.97M | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -113.41K | -37.06K | 18.57K | -129.71K | -3.72M | -630.05K | -1.56M | -300.38K | -68.69K | -10.17M | -12.91K | -23.55K | -19.85K | -4.13K | 0 |
| CapEx % of Revenue | 0% | 0.01% | 0.01% | 0.05% | 0.08% | 28.73% | 8.69% | 3% | 11.51% | 280.64% | 73.85% | 249.92% | 717.2% | 5.12% | 562.18% | 2.84% | 0.76% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -34.97M | 0 |
| Cash from Financing | 851.64K | 4.21M | 1.9M | 4.61M | -53.1K | 6.62M | 2.8M | 1.92M | 4.22M | -15.25K | -8.9K | 7.71K | 1.9K | -39.85K | 6.3M | 6K | 2.27K | 6.1K | 50.16M | -814.85K |
| Debt Issued (Net) | -259.3K | -32.85K | -31.39K | 119.08K | -32.46K | 343.99K | 2.8M | 1.92M | 1.72M | -29.29K | -8.98K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1.11M | 4.57M | 1.93M | 649.39K | 1.65K | 3.96M | 0 | 0 | 2.5M | 14.04K | 84 | 7.71K | 1.9K | 5.83K | 1.67K | 6K | 2.27K | 6.1K | 56M | 9.46K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -321.38K | 0 | 3.85M | -22.3K | 2.32M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -45.68K | 6.3M | 0 | 0 | 0 | -5.84M | -824.31K |
| Net Change in Cash | -723.59K | 855.55K | -1.34M | 1.33M | -3.57M | 3.68M | -163.09K | -2.92M | 488.98K | -7.63M | 3.77M | -10.94M | -3.94M | -3.9M | 10.8M | -2.7M | 6.39M | -3.39M | 10.07M | -1.81M |
| Free Cash Flow | -1.58M | -3.36M | -3.24M | -3.28M | -3.51M | -2.95M | -2.96M | -4.84M | -3.73M | -7.61M | -6.22M | -10.95M | -3.94M | -3.86M | -12.48M | -2.7M | -1.62M | -3.4M | -5.12M | -990.44K |
| FCF Margin % | -24.07% | -12423.25% | -20760.86% | -50111.45% | -69375.32% | -746.77% | -694.98% | -782.68% | -331.37% | -574.81% | -729.02% | -1757.91% | -9403.81% | -287.59% | -690.14% | -595.32% | -51.83% | - | - | - |
| FCF Growth % | 55.17% | -13.81% | -9.33% | 32.23% | 5.88% | 61.26% | 52.35% | 55.76% | 5.21% | -97.26% | 50.18% | -305.08% | -143.77% | -13.59% | -143.7% | -172.88% | -6.78% | 4.96% | - | - |
| FCF per Share | -4.51 | -9.60 | -8.60 | -11.06 | -0.47 | -0.46 | -0.47 | -0.77 | -0.60 | -1.27 | -1.04 | -1.83 | -0.66 | -0.65 | -2.09 | -0.45 | -0.27 | -0.69 | -1.04 | -0.17 |
| FCF Conversion (FCF/Net Income) | -0.38x | -4.67x | 0.71x | 1.70x | 1.60x | 0.84x | 0.75x | 0.32x | 0.48x | 0.36x | 1.13x | 2.18x | 0.72x | 0.70x | 0.59x | 0.77x | 0.77x | 1.06x | 1.25x | 0.36x |
| Interest Paid | 0 | 0 | 0 | 159.89K | 244.27K | 228.78K | 181.32K | 159.67K | 0 | -1.42K | 95.51K | 95.51K | 93.44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |